BIOCERES CROP SOLUTIONS Reports Record USD 93 Million Revenue for Q3 2023, Up 36.3% YOY

June 1, 2023

☀️Earnings Overview

BIOCERES CROP SOLUTIONS ($NASDAQ:BIOX) reported that total revenue for the fiscal year 2023 third quarter (ending March 31 2023) was USD 93.0 million, showing a 36.3% improvement year-on-year. Net income for the quarter was USD 28.2 million, compared to a net loss of -6.5 million in the same period last year. This information was released on May 24 2023.

Analysis

GoodWhale offers investors the opportunity to analyze the fundamentals of BIOCERES CROP SOLUTIONS with their platform. After a thorough analysis, GoodWhale gave BIOCERES CROP SOLUTIONS a high risk rating in terms of both financial and business aspects. GoodWhale also detected two risk warnings in the income sheet and balance sheet of the company. If you would like to take a closer look at the risks, you can register on GoodWhale.com for more in-depth information. With GoodWhale, you can make sure that you are making an informed decision when investing in BIOCERES CROP SOLUTIONS. More…

  • Risk Rating Analysis
  • Star Chart Analysis
  • Valuation Analysis
  • About the Company

  • Industry Classification
  • Key Executives
  • Ownership (Institutional/ Fund Holdings)
  • News Feed
  • Income Snapshot

    Below shows the total revenue, net income and net margin for BIOX. More…

    Total Revenues Net Income Net Margin
    415.93 15.47 5.6%
  • Income Statement Reports (Yearly/ Quarterly/ LTM)
  • Income Supplement
  • Growth Performance
  • Cash Flow Snapshot

    Below shows the cash from operations, investing and financing for BIOX. More…

    Operations Investing Financing
    5.66 -23.87 31.22
  • Cash Flow Statement (Yearly/ Quarterly/ LTM)
  • Cash Flow Supplement
  • Balance Sheet Snapshot

    Below shows the total assets, liabilities and book value per share for BIOX. More…

    Total Assets Total Liabilities Book Value Per Share
    846.8 512.53 4.75
  • Balance Sheet (Yearly/ Quarterly)
  • Balance Sheet Supplement
  • Key Ratios Snapshot

    Some of the financial key ratios for BIOX are shown below. More…

    3Y Rev Growth 3Y Operating Profit Growth Operating Margin
    33.8% 22.8% 11.5%
    FCF Margin ROE ROA
    -3.0% 10.4% 3.5%
  • Income Statement Ratios
  • Balance Sheet Ratios
  • Cash Flow Ratios
  • Valuation Ratios
  • Other Ratios
  • Other Supplementary Items




  • Peers

    In the world of agriculture, there are many companies vying for supremacy. Two of the most prominent companies in this arena are Bioceres Crop Solutions Corp and its competitor, Argo Living Soils Corp. Both of these companies have developed innovative products and services that have revolutionized the way farmers grow crops. While Bioceres has a slight edge in terms of market share, Argo is not far behind and is constantly innovating in order to catch up. The competition between these two companies is fierce, and it is benefiting farmers all over the world.

    – Argo Living Soils Corp ($OTCPK:ARLSF)

    Argo Living Soils Corp is a Canadian company that specializes in the production of organic soils and amendments. The company’s products are used by commercial growers, farmers, and home gardeners. Argo Living Soils Corp has a market cap of 1.61M as of 2022. The company’s return on equity is 83.33%.

    – EarthRenew Inc ($OTCPK:VVIVF)

    The company’s market cap is 13.41M as of 2022. The company’s ROE is -24.3%. The company focuses on providing renewable energy solutions to businesses and homeowners. The company operates in three segments: Solar, Wind, and Other. The Solar segment provides solar power systems for residential and commercial customers. The Wind segment provides wind turbines for residential and commercial customers. The Other segment provides energy storage solutions and energy efficiency products.

    – Kiwa Bio-Tech Products Group Corp ($OTCPK:KWBT)

    Kiwa Bio-Tech Products Group Corp is a China-based company that engages in the research, development, manufacture, and sale of bio-pesticides and bio-fertilizers. The company has a market cap of 56.48k as of 2022 and a Return on Equity of -5.54%. Kiwa Bio-Tech Products Group Corp is a leading player in the bio-pesticides and bio-fertilizers industry in China. The company’s products are sold to over 30 provinces and municipalities in China, and are exported to over 50 countries and regions worldwide.

    Summary

    BIOCERES CROP SOLUTIONS reported strong financial results for the fiscal year 2023 third quarter ending March 31, 2023. Total revenue for the quarter was USD 93 million, an increase of 36.3% year over year. Net income of USD 28.2 million was reported, a significant improvement from the same period last year at -6.5 million dollars. These impressive results caused the stock price to move up the same day.

    These figures suggest that investing in BIOCERES CROP SOLUTIONS could be a sound decision. With growing revenue and increased profitability, the company is well-positioned to take advantage of opportunities in the future and deliver strong returns for investors.

    Recent Posts

    Leave a Comment